Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neflamapimod in MCI due to AD or Mild AD
NCT02423200Phase 2Completed
- Sponsor
- CervoMed
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of neflamapimod in Alzheimer's disease (AD), sponsored by CervoMed. Started Apr 2015; status: completed.
02
Drugs
neflamapimod
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT02423200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02423200.